Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $912,000 | $2,530,000 | $2,259,000 | $2,559,000 |
| % Growth | -64% | 12% | -11.7% | – |
| Cost of Goods Sold | -$668,000 | $764,000 | $701,000 | $727,000 |
| Gross Profit | $1,580,000 | $1,766,000 | $1,558,000 | $1,832,000 |
| % Margin | 173.2% | 69.8% | 69% | 71.6% |
| R&D Expenses | $166,000 | $160,000 | $171,000 | $163,000 |
| G&A Expenses | $0 | $0 | $0 | $30,000 |
| SG&A Expenses | $795,000 | $894,000 | $862,000 | $816,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $786,000 |
| Other Operating Expenses | $0 | $268,000 | $249,000 | $295,000 |
| Operating Expenses | $961,000 | $1,322,000 | $1,282,000 | $1,274,000 |
| Operating Income | $619,000 | $444,000 | $276,000 | $558,000 |
| % Margin | 67.9% | 17.5% | 12.2% | 21.8% |
| Other Income/Exp. Net | -$401,000 | -$304,000 | -$323,000 | -$349,000 |
| Pre-Tax Income | $218,000 | $140,000 | -$47,000 | $209,000 |
| Tax Expense | $39,000 | $12,000 | $39,000 | $111,000 |
| Net Income | $179,000 | $148,000 | -$58,000 | $93,000 |
| % Margin | 19.6% | 5.8% | -2.6% | 3.6% |
| EPS | -0.24 | 0.4 | -0.16 | 0.25 |
| % Growth | -160% | 350% | -164% | – |
| EPS Diluted | -0.24 | 0.4 | -0.16 | 0.25 |
| Weighted Avg Shares Out | 370,900 | 370,900 | 362,500 | 372,000 |
| Weighted Avg Shares Out Dil | 373,100 | 373,100 | 362,500 | 372,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15,000 | $13,000 | $11,000 | $9,000 |
| Interest Expense | $2,002,000 | $465,000 | $330,000 | $337,000 |
| Depreciation & Amortization | $300,000 | $307,000 | $305,000 | $307,000 |
| EBITDA | $2,520,000 | $764,000 | $602,000 | $901,000 |
| % Margin | 276.3% | 30.2% | 26.6% | 35.2% |